Board of Directors

Director

Mr. Brynelsen is nominated to be elected the chairman of the New Envoy Board upon closing of the merger with Anzu. Mr. Brynelsen has extensive experience in the medical device industry, including most recently serving as Senior Vice President and President of Abbott Vascular from 2017 to 2021. Since 2015 he has also been a Venture Partner of SpringRock Ventures, an investment firm that focuses on digital health, devices, services, oral health, SAAS, consumerization/ecommerce of healthcare, IT and wellness. Mr. Brynelsen has also served on the boards of private companies including Alebra Technologies since 2010, and Neuspera Medical from 2022 to 2023. Mr. Brynelsen previously served as Senior Vice President and President of Medtronic Early Technologies from 2015 to 2016, as the Global President of Covidien Early Technologies from 2013 to 2015, and as the Chief Executive Officer of IntraPace from 2005 to 2012. Mr. Brynelsen received his BA from Bradley University and MBA from Kellogg School of Management at Northwestern University.

Director

Mr. Lucas is nominated to be elected as Chief Executive Officer and a member of the New Envoy Board. Mr. Lucas has served as Chief Executive Officer of Envoy for the past seven years and brings over 15 years of experience in the hearing health industry. He has served in various roles with Envoy and gained a tremendous amount of specialized experience, working his way up from an intern to CEO. Mr. Lucas received his bachelor’s degree from the University of St. Thomas and Juris Doctor degree from the Mitchell Hamline School of Law.

Director

Ms. Kantor is nominated to be elected as an independent member of the New Envoy Board and chair the audit ommittee. Ms. Kantor has experience leading international finance, tax, treasury, risk, compliance and technology enablement for global services organizations. She was an Advisory Partner for PwC from 2011 to 2016, a Partner and CFO & Treasurer of PRTM Management Consultants from 1997 to 2011 and was previously a CFO/senior financial executive at corporate strategy and operations consulting firms Monitor Group and BCG. Ms. Kantor is currently on the boards and serves as Audit Committee chair of Anzu, Teknor Apex Company, Guest Services Inc., and the International Council on Clean Transportation. She received her bachelor’s degree from Grove City College in Accounting and Business Administration and her CPA in MA.

Director

Ms. Smith-Gomez is nominated to be elected as an independent member of the New Envoy Board and chair the nominating and corporate governance committee. Ms. Smith-Gomez has more than 30 years of experience in marketing and innovation, positioning global brands for growth and competitive advantage, contributing to her strong business acumen and stakeholder insights focus. From 2006 to 2022, Ms. Smith-Gomez held a variety of leadership positions at Johnson & Johnson across medical devices and consumer health, where she focused on building brands, launch excellence and innovative marketing strategies for revenue and market share growth. Prior to working at Johnson & Johnson, Ms. SmithGomez held the roles of Vice President of Marketing at Mars, Incorporated, Senior Director at Kraft Foods, and the Director of Marketing at PepsiCo, Inc. Ms. Smith-Gomez received her bachelor’s degree in Professional Option: Business, and her M.B.A. from the University of Chicago.

Independent Director

Michael Crowe is currently the SVP Operations at Bioventus. In this role he oversees Operations, Supply Chain, Customer Service, Data Integrity, Facilities, Sustaining Engineering, and the Office of Project Management & Alliances reporting to him.Mr. Crowe began his career at General Electric, and has served in management at medical device powerhouses Johnson & Johnson, Covidien Surgical Devices (now part of Medtronic), and Abbott Vascular. Michael holds a BS in electrical engineering from the University of Louisville and an MBA from Duke. He is also a certified master black belt in Six Sigma, and lean manufacturing and is a trained facilitator and continuous improvement champion.

Director

Ms. Patel is nominated to be elected as an independent member of the New Envoy Board. Ms. Patel has over 30 years of experience with medical devices in marketing, market development, clinical education and mergers and acquisitions. Currently, Ms. Patel works as a strategic advisor for med-tech start-ups, through which she helps companies raise funding, understand market opportunities, and develop go-tomarket plans. She has extensive experience working for notable healthcare companies such as Boston Scientific, Guidant and Abbott Labs. Ms. Patel earned a BSE in Mechanical Engineering from the University of Michigan, and an M.B.A. from the University of Pennsylvania, Wharton School of Business.

Director

Mr. Taylor is nominated to be elected as a member of the New Envoy Board and Chairman Emeritus. Mr. Taylor is the founder and chairman of Taylor Corporation, a global printing and communications company and one of the nation’s largest privately held companies. Among other investments, Mr. Taylor is owner of the Minnesota StarTribune and owner and chairman of Taylor Sports Group, Inc., the general partner of Minnesota Timberwolves Basketball Limited Partnership. In addition, Mr. Taylor is a member (and former chair) of the Board of Governors of the National Basketball Association, served in the Minnesota State Senate from 1980 to 1990 and as Minority Leader from 1985 to 1988. Mr. Taylor attended Harvard Graduate School of Business and earned his Bachelor of Science at Minnesota State University in Mankato.